STRATA Skin Sciences to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 11
HORSHAM, Pa. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences Reports First Quarter 2020 Financial Results
Recurring revenue for the first quarter of 2020 grew 7.3% over first quarter 2019 Total gross margins in the first quarter of 2020 grew 3.8% over first quarter 2019 Global recurring revenue installed base totaled 838 systems at March 31, 2020 Conference call and webcast, today at 8:30 am Eastern
STRATA Skin Sciences to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 12
HORSHAM, Pa. , May 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences, Inc. Receives Forgivable Loan Under the Paycheck Protection Program
$2.0 million forgivable loan received Provides further business update - Initiating the Patient Outreach Program HORSHAM, Pa. , April 27, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery
STRATA Skin Sciences, Inc. Announces Preliminary First Quarter 2020 Revenue and Provides Business Update
Preliminary unaudited total revenue for the first quarter of 2020 is expected to be in the range of $6.7 and $6.9 million , consistent with guidance previously given Global recurring revenue installed base totaled 838 systems at March 31, 2020 HORSHAM, Pa.
STRATA Skin Sciences, Inc. Announces Study Published in the Journal of Drugs in Dermatology
92% of participants achieved reduction in mPASI score of 75% or more after receiving Optimal Therapeutic Dose Therapy with the Multi-Micro Dose® diagnostic tip for the treatment of their plaque psoriasis HORSHAM, Pa. , April 06, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.
STRATA Skin Sciences Reports Fourth Quarter and Year End 2019 Financial Results
Recurring revenues grew 12.6% in 2019 Total gross margins increased 6.9% in 2019 Global recurring revenue installed base totaled 830 systems at year end 2019 Conference call and webcast, today at 8:30 am Eastern Time HORSHAM, Pa. , March 17, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.
STRATA Skin Sciences to Host Fourth Quarter and Year End 2019 Financial Results and Business Update Conference call on March 17
HORSHAM, Pa. , March 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences, Inc. Receives A 510(k) Clearance For Its XTRAC Momentum 308nm Excimer Laser Platform
New features include increased power range, short-hair scalp tip and on-board database to improve patient safety, treatment efficiency and ease-of-use HORSHAM, Pa. , Jan. 23, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company
STRATA Skin Sciences, Inc. Announces Preliminary Q4 FY 2019 Revenue and Key Financial Metrics
Preliminary, unaudited fourth quarter revenues in the range of $8.8 million to $8.85 million Preliminary, unaudited fourth quarter recurring revenues in the range of $6.5 million to $6.55 million Preliminary, unaudited fourth quarter revenues result in double digit growth Domestic installed base